Kyung Jin Kim,Wei-meng Zhao,Hangil Park,Maximiliano Vasquez
申请号：
US14071520
公开号：
US09382324B2
申请日:
2013.11.04
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
